株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界のナトリウム・グルコース共輸送体 2(SGLT2)阻害剤市場:成長、動向、競合分析(2019年~2025年)

Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

発行 QYResearch 商品コード 916065
出版日 ページ情報 英文 110 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=110.56円で換算しております。
Back to Top
世界のナトリウム・グルコース共輸送体 2(SGLT2)阻害剤市場:成長、動向、競合分析(2019年~2025年) Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
出版日: 2019年11月11日 ページ情報: 英文 110 Pages
概要

当レポートは世界のナトリウム・グルコース共輸送体 2(SGLT2)阻害剤市場について調査しており、市場動向、成長要因、用途・タイプ・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 レポートの概要

  • 調査範囲
  • 当レポートの対象となる主要メーカー
  • 市場セグメント:タイプ別
    • 市場規模の成長率
    • Invokana(カナグリフロジン)
    • Jardiance(エンパグリフロジン)
    • Forxiga(ダパグリフロジン)
    • Suglat(イプラグリフロジン)
  • 市場セグメント:用途別
    • 市場のシェア
    • 病院
    • 医学研究所
    • その他
  • 調査の目的
  • 考慮される年

第2章 世界の成長動向

  • 市場規模
    • 収益
    • 取引量
  • 成長率:地域別
    • 取引量
    • 収益
  • 産業の動向
    • 市場の主な動向
    • 市場成長要因

第3章 市場シェア:メーカ別

  • 取引量
    • 取引量
    • 販売の市場シェア
  • 収益
    • 収益
    • 収益の市場シェア
    • 市場集中率(CR5およびHHI)
  • 価格
  • 主要メーカーの工場分布および提供エリア
  • 主要メーカーの市場参入日
  • 主要メーカーの提供製品
  • 合併・買収、拡張計画

第4章 市場規模:タイプ別

  • 取引量・収益
    • Invokana(カナグリフロジン)
    • Jardiance(エンパグリフロジン)
    • Forxiga(ダパグリフロジン)
    • Suglat(イプラグリフロジン)
  • 取引量の市場シェア
  • 収益の市場シェア
  • 価格

第5章 市場規模:用途別

  • 概要
  • 取引量

第6章 北米

  • 企業別
  • タイプ別
  • 用途別
  • 国別
    • 取引量
    • 収益
    • 米国
    • カナダ
    • メキシコ

第7章 欧州

  • ドイツ
  • フランス
  • 英国
  • イタリア
  • ロシア

第8章 アジア太平洋地域

  • 中国
  • 日本
  • 韓国
  • インド
  • オーストラリア
  • インドネシア
  • タイ
  • マレーシア
  • フィリピン
  • ベトナム

第9章 中南米

  • ブラジル

第10章 中東・アフリカ

  • トルコ
  • GCC諸国
  • エジプト
  • 南アフリカ

第11章 企業プロファイル

  • Eli Lilly
  • Janssen Pharmaceuticals
  • Astellas
  • Boehringer Ingelheim
  • AstraZeneca
  • Bristol Myers Squibb
  • 寿製薬株式会社

第12章 バリューチェーン・販売チャネル分析

  • バリューチェーン分析
  • 販売チャネル分析
    • 販売チャネル
    • 卸売業者
  • 顧客

第13章 市場予測

  • 取引量・収益予測
  • 種類別取引量予測
  • 用途別取引量予測
  • 地域別予測
    • 取引量予測
    • 収益予測
  • 北米市場
    • 国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州市場
    • 国別
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
  • アジア太平洋地域市場
    • 地域別
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • インドネシア
    • タイ
    • マレーシア
    • フィリピン
    • ベトナム
  • 中南米市場
    • 国別
    • ブラジル
  • 中東・アフリカ市場
    • 国別
    • トルコ
    • GCC諸国
    • エジプト
    • 南アフリカ

第14章 調査結果・結論

第15章 付録

  • 調査方法
    • 調査方法/調査アプローチ
    • 情報源
  • 著者の詳細
  • 免責事項
図表

List of Tables and Figures

  • Figure Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Picture
  • Table Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Key Market Segments
  • Table Major Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Covered in This Report
  • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Growth Rate by Type 2019-2025 (Kg) & (Million US$)
  • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Shar by Type 2014-2025
  • Figure Invokana (Canagliflozin) Figures
  • Table Major Manufacturers of Invokana (Canagliflozin)
  • Figure Jardiance (Empagliflozin) Figures
  • Table Major Manufacturers of Jardiance (Empagliflozin)
  • Figure Farxiga/Forxiga (Dapagliflozin) Figures
  • Table Major Manufacturers of Farxiga/Forxiga (Dapagliflozin)
  • Figure Suglat (Ipragliflozin) Figures
  • Table Major Manufacturers of Suglat (Ipragliflozin)
  • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Application 2019-2025 (Kg)
  • Figure Hospital Use Case
  • Figure Medical Research Institute Use Case
  • Figure Other Use Case
  • Figure Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Report Years Considered
  • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size 2014-2025 (Million US$)
  • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales 2014-2019 (Kg)
  • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size by Regions 2014-2019 (Kg) & (Million US$)
  • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Regions 2014-2019 (Kg)
  • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Regions 2014-2019
  • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Regions 2014-2019
  • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Regions in 2018
  • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Regions 2014-2019 (Million US$)
  • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Regions 2014-2019
  • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Regions 2014-2019
  • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Regions in 2018
  • Table Market Top Trends
  • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Manufacturers (2014-2019) (Kg)
  • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Manufacturers (2014-2019)
  • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Manufacturers in 2018
  • Table Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Manufacturers (2014-2019) (Million USD)
  • Table Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Share by Manufacturers (2014-2019)
  • Figure Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Value Share by Manufacturers in 2018
  • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table Key Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price (2014-2019) (USD/Kg)
  • Table Key Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Plants/Factories Distribution
  • Table Key Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Area Served
  • Table Date of Key Manufacturers Enter into Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market
  • Table Key Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Type
  • Table Mergers & Acquisitions, Expansion Plans
  • Table Global Invokana (Canagliflozin) Sales an目??出!D Revenue (2014-2019) (Kg) & (Million US$)
  • Table Global Jardiance (Empagliflozin) Sales an目??出!D Revenue (2014-2019) (Kg) & (Million US$)
  • Table Global Farxiga/Forxiga (Dapagliflozin) Sales an目??出!D Revenue (2014-2019) (Kg) & (Million US$)
  • Table Global Suglat (Ipragliflozin) Sales an目??出!D Revenue (2014-2019) (Kg) & (Million US$)
  • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2014-2019) (Kg)
  • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Type (2014-2019)
  • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2014-2019)
  • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type in 2018
  • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Type (2014-2019) (Million US$)
  • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Share by Type (2014-2019)
  • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Type (2014-2019)
  • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Type in 2018
  • Table Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Type 2014-2019 (USD/Kg)
  • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2014-2019) (Kg)
  • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Share by Application (2014-2019)
  • Figure Global Sales Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Application (2014-2019)
  • Figure Global Sales Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Application in 2018
  • Figure North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate 2014-2019 (Kg)
  • Figure North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
  • Table North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Company (2014-2019) (Kg)
  • Table North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Company (2014-2019)
  • Figure North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Company in 2018
  • Table North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2014-2019) (Kg)
  • Table North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2014-2019)
  • Figure North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Type in 2018
  • Table North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2014-2019) (Kg)
  • Table North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2014-2019)
  • Figure North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Application in 2018
  • Table North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Countries (2014-2019) (Kg)
  • Table North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Countries (2014-2019)
  • Figure North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Countries in 2018
  • Table North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Countries (2014-2019) (Million US$)
  • Table North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Countries (2014-2019)
  • Figure North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Countries in 2018
  • Figure United States Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2014-2019) (Kg)
  • Figure Canada Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2014-2019) (Kg)
  • Figure Mexico Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2014-2019) (Kg)
  • Figure Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate 2014-2019 (Kg)
  • Figure Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
  • Table Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Company (2014-2019) (Kg)
  • Table Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Company (2014-2019)
  • Figure Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Company in 2018
  • Table Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2014-2019) (Kg)
  • Table Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2014-2019)
  • Figure Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type in 2018
  • Table Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2014-2019) (Kg)
  • Table Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2014-2019)
  • Figure Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application in 2018
  • Table Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Countries (2014-2019) (Kg)
  • Table Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Countries (2014-2019)
  • Figure Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Countries in 2018
  • Table Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Countries (2014-2019) (Million US$)
  • Table Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Countries (2014-2019)
  • Figure Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Countries in 2018
  • Figure Germany Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2014-2019) (Kg)
  • Figure France Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2014-2019) (Kg)
  • Figure UK Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2014-2019) (Kg)
  • Figure Italy Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2014-2019) (Kg)
  • Figure Russia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2014-2019) (Kg)
  • Figure Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate 2014-2019 (Kg)
  • Figure Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
  • Table Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Regions (2014-2019) (Kg)
  • Table Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Regions (2014-2019)
  • Figure Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Regions in 2018
  • Table Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2014-2019) (Kg)
  • Table Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2014-2019)
  • Figure Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Type in 2018
  • Table Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2014-2019) (Kg)
  • Table Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2014-2019)
  • Figure Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Application in 2018
  • Table Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Countries (2014-2019) (Kg)
  • Table Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Regions (2014-2019)
  • Figure Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Regions in 2018
  • Table Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Regions (2014-2019) (Million US$)
  • Table Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Regions (2014-2019)
  • Figure Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Regions in 2018
  • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2014-2019) (Kg)
  • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2014-2019) (Kg)
  • Figure Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Korea Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2014-2019) (Kg)
  • Figure Korea Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
  • Figure India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2014-2019) (Kg)
  • Figure India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Australia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2014-2019) (Kg)
  • Figure Australia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Indonesia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2014-2019) (Kg)
  • Figure Indonesia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Malaysia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2014-2019) (Kg)
  • Figure Malaysia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Philippines Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2014-2019) (Kg)
  • Figure Philippines Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Thailand Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2014-2019) (Kg)
  • Figure Thailand Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Vietnam Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2014-2019) (Kg)
  • Figure Vietnam Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2014-2019) (Million US$)
  • Figure Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate 2014-2019 (Kg)
  • Figure Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
  • Table Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Company (2014-2019) (Kg)
  • Table Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Company (2014-2019)
  • Figure Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Company in 2018
  • Table Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2014-2019) (Kg)
  • Table Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2014-2019)
  • Figure Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Type in 2018
  • Table Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2014-2019) (Kg)
  • Table Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2014-2019)
  • Figure Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Application in 2018
  • Table Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Countries (2014-2019) (Kg)
  • Table Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Countries (2014-2019)
  • Figure Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Countries in 2018
  • Table Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Countries (2014-2019) (Million US$)
  • Table Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Countries (2014-2019)
  • Figure Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Countries in 2018
  • Figure Brazil Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2014-2019) (Kg)
  • Figure Brazil Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2014-2019) (Kg)
  • Figure Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate 2014-2019 (Kg)
  • Figure Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate 2014-2019 (Million US$)
  • Table Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Type (2014-2019) (Kg)
  • Table Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type (2014-2019)
  • Figure Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type in 2018
  • Table Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application (2014-2019) (Kg)
  • Table Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application (2014-2019)
  • Figure Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Application in 2018
  • Table Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Countries (2014-2019) (Kg)
  • Table Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Countries (2014-2019)
  • Figure Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Countries in 2018
  • Table Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Countries (2014-2019) (Million US$)
  • Table Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Countries (2014-2019)
  • Figure Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Countries in 2018
  • Figure GCC Countries Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2014-2019) (Kg)
  • Figure GCC Countries Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2014-2019) (Kg)
  • Figure Egypt Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2014-2019) (Kg)
  • Figure Egypt Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2014-2019) (Kg)
  • Figure South Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2014-2019) (Kg)
  • Figure South Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Growth Rate (2014-2019) (Kg)
  • Table Eli Lilly Company Details
  • Table Eli Lilly Description and Business Overview
  • Table Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
  • Table Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2014-2019)
  • Table Eli Lilly Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Global Market
  • Table Eli Lilly Recent Development
  • Table Janssen Pharmaceuticals Company Details
  • Table Janssen Pharmaceuticals Description and Business Overview
  • Table Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
  • Table Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2014-2019)
  • Table Janssen Pharmaceuticals Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Global Market
  • Table Janssen Pharmaceuticals Recent Development
  • Table Astellas Company Details
  • Table Astellas Description and Business Overview
  • Table Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
  • Table Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2014-2019)
  • Table Astellas Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Global Market
  • Table Astellas Recent Development
  • Table Boehringer Ingelheim Company Details
  • Table Boehringer Ingelheim Description and Business Overview
  • Table Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
  • Table Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2014-2019)
  • Table Boehringer Ingelheim Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Global Market
  • Table Boehringer Ingelheim Recent Development
  • Table AstraZeneca Company Details
  • Table AstraZeneca Description and Business Overview
  • Table AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
  • Table AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2014-2019)
  • Table AstraZeneca Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Global Market
  • Table AstraZeneca Recent Development
  • Table Bristol Myers Squibb Company Details
  • Table Bristol Myers Squibb Description and Business Overview
  • Table Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
  • Table Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2014-2019)
  • Table Bristol Myers Squibb Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Global Market
  • Table Bristol Myers Squibb Recent Development
  • Table Kotobuki Pharmaceutical Company Details
  • Table Kotobuki Pharmaceutical Description and Business Overview
  • Table Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2014-2019)
  • Table Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Growth Rate (2014-2019)
  • Table Kotobuki Pharmaceutical Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share in Global Market
  • Table Kotobuki Pharmaceutical Recent Development
  • Figure Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Value Chain
  • Table Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Distributors List
  • Table Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Customers List
  • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast 2019-2025 (Kg) & (Million US$)
  • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast 2019-2025 (Kg)
  • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast 2019-2025 (Million US$)
  • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Type 2019-2025 (Kg)
  • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Type 2019-2025 (Kg)
  • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share Forecast by Type 2019-2025
  • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Application 2019-2025 (Kg)
  • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Application 2019-2025 (Kg)
  • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share Forecast by Application 2019-2025
  • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Regions 2019-2025 (Kg)
  • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Regions 2019-2025 (Kg)
  • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share Forecast by Regions 2019-2025
  • Table Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Regions 2019-2025 (Million US$)
  • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Regions 2019-2025 (Million US$)
  • Figure Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share Forecast by Regions 2019-2025
  • Table North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Countries 2019-2025 (Kg)
  • Table North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share Forecast by Countries 2019-2025
  • Table North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Countries 2019-2025 (Million US$)
  • Table North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share Forecast by Countries 2019-2025
  • Figure United States Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast 2019-2025 (Kg)
  • Figure Canada Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast 2019-2025 (Kg)
  • Figure Mexico Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast 2019-2025 (Kg)
  • Table Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Countries 2019-2025 (Kg)
  • Table Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share Forecast by Countries 2019-2025
  • Table Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Countries 2019-2025 (Million US$)
  • Table Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share Forecast by Countries 2019-2025
  • Figure Germany Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast 2019-2025 (Kg)
  • Figure France Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast 2019-2025 (Kg)
  • Figure UK Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast 2019-2025 (Kg)
  • Figure Italy Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast 2019-2025 (Kg)
  • Figure Russia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast 2019-2025 (Kg)
  • Table Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Regions 2019-2025 (Kg)
  • Table Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share Forecast by Regions 2019-2025
  • Table Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Regions 2019-2025 (Million US$)
  • Table Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share Forecast by Regions 2019-2025
  • Figure China Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast 2019-2025 (Kg)
  • Figure Japan Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast 2019-2025 (Kg)
  • Figure South Korea Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast 2019-2025 (Kg)
  • Figure India Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast 2019-2025 (Kg)
  • Figure Australia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast 2019-2025 (Kg)
  • Figure Indonesia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast 2019-2025 (Kg)
  • Figure Thailand Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast 2019-2025 (Kg)
  • Figure Malaysia Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast 2019-2025 (Kg)
  • Figure Philippines Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast 2019-2025 (Kg)
  • Figure Vietnam Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast 2019-2025 (Kg)
  • Table Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Countries 2019-2025 (Kg)
  • Table Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share Forecast by Countries 2019-2025
  • Table Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Countries 2019-2025 (Million US$)
  • Table Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share Forecast by Countries 2019-2025
  • Figure Brazil Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast 2019-2025 (Kg)
  • Table Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Regions 2019-2025 (Kg)
  • Table Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share Forecast by Regions 2019-2025
  • Table Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Regions 2019-2025 (Million US$)
  • Table Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share Forecast by Regions 2019-2025
  • Figure Turkey Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast 2019-2025 (Kg)
  • Figure GCC Countries Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast 2019-2025 (Kg)
  • Figure Egypt Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast 2019-2025 (Kg)
  • Figure South Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast 2019-2025 (Kg)
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
目次

SGLT2 is a member of the sodium-glucose cotransporter family which are sodium-dependent glucose transport proteins. SGLT2 is the major cotransporter involved in glucose reabsorption in the kidney.The growing global type-2 diabetes population promotes the growth of SGLT2 drugs.

In 2018, the global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors.

This study researches the market size of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors, presents the global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.

This report focuses on the key data information of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors in key regions like North America, Europe, China and Japan, presents sales, revenue, market share, growth rate of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors for each region and countries in each region.

For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.

This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.

  • Eli Lilly
  • Janssen Pharmaceuticals
  • Astellas
  • Boehringer Ingelheim
  • AstraZeneca
  • Bristol Myers Squibb
  • Kotobuki Pharmaceutical
  • ...

Market Segment by Product Type

  • Invokana (Canagliflozin)
  • Jardiance (Empagliflozin)
  • Farxiga/Forxiga (Dapagliflozin)
  • Suglat (Ipragliflozin)

Market Segment by Application

  • Hospital
  • Medical Research Institute
  • Other

Market size split by Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

The study objectives are:

  • To analyze and research the global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
  • To present the key Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors manufacturers, capacity, production, revenue, market share, and recent development for key players.
  • To split the breakdown data by regions, type, companies and applications.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends, drivers, influence factors in global and regions.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors are as follows:

  • History Year: 2014-2019
  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Year 2019 to 2025

Table of Contents

1 Report Overview

  • 1.1 Research Scope
  • 1.2 Major Manufacturers Covered in This Report
  • 1.3 Market Segment by Type
    • 1.3.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size Growth Rate by Type
    • 1.3.2 Invokana (Canagliflozin)
    • 1.3.3 Jardiance (Empagliflozin)
    • 1.3.4 Farxiga/Forxiga (Dapagliflozin)
    • 1.3.5 Suglat (Ipragliflozin)
  • 1.4 Market Segment by Application
    • 1.4.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Share by Application (2019-2025)
    • 1.4.2 Hospital
    • 1.4.3 Medical Research Institute
    • 1.4.4 Other
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Size
    • 2.1.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue 2014-2025
    • 2.1.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales 2014-2025
  • 2.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Growth Rate by Regions
    • 2.2.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Regions 2014-2019
    • 2.2.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Regions 2014-2019
  • 2.3 Industry Trends
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers

3 Market Share by Manufacturers

  • 3.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Manufacturers
    • 3.1.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Manufacturers 2014-2019
    • 3.1.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Manufacturers 2014-2019
  • 3.2 Revenue by Manufacturers
    • 3.2.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Manufacturers (2014-2019)
    • 3.2.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Share by Manufacturers (2014-2019)
    • 3.2.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Concentration Ratio (CR5 and HHI)
  • 3.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Manufacturers
  • 3.4 Key Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Plants/Factories Distribution and Area Served
  • 3.5 Date of Key Manufacturers Enter into Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market
  • 3.6 Key Manufacturers Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Offered
  • 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Sales and Revenue for Each Type
    • 4.1.1 Invokana (Canagliflozin) Sales and Revenue (2014-2019)
    • 4.1.2 Jardiance (Empagliflozin) Sales and Revenue (2014-2019)
    • 4.1.3 Farxiga/Forxiga (Dapagliflozin) Sales and Revenue (2014-2019)
    • 4.1.4 Suglat (Ipragliflozin) Sales and Revenue (2014-2019)
  • 4.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Market Share by Type
  • 4.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Market Share by Type
  • 4.4 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Price by Type

5 Market Size by Application

  • 5.1 Overview
  • 5.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Application

6 North America

  • 6.1 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Breakdown Data by Company
  • 6.2 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Breakdown Data by Type
  • 6.3 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Breakdown Data by Application
  • 6.4 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Breakdown Data by Countries
    • 6.4.1 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Countries
    • 6.4.2 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Countries
    • 6.4.3 United States
    • 6.4.4 Canada
    • 6.4.5 Mexico

7 Europe

  • 7.1 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Breakdown Data by Company
  • 7.2 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Breakdown Data by Type
  • 7.3 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Breakdown Data by Application
  • 7.4 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Breakdown Data by Countries
    • 7.4.1 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Countries
    • 7.4.2 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Countries
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 UK
    • 7.4.6 Italy
    • 7.4.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Breakdown Data by Company
  • 8.2 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Breakdown Data by Type
  • 8.3 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Breakdown Data by Application
  • 8.4 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Breakdown Data by Regions
    • 8.4.1 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Countries
    • 8.4.2 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Countries
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 India
    • 8.4.7 Australia
    • 8.4.8 Indonesia
    • 8.4.9 Thailand
    • 8.4.10 Malaysia
    • 8.4.11 Philippines
    • 8.4.12 Vietnam

9 Central & South America

  • 9.1 Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Breakdown Data by Company
  • 9.2 Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Breakdown Data by Type
  • 9.3 Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Breakdown Data by Application
  • 9.4 Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Breakdown Data by Countries
    • 9.4.1 Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Countries
    • 9.4.2 Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Countries
    • 9.4.3 Brazil

10 Middle East and Africa

  • 10.1 Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Breakdown Data by Type
  • 10.2 Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Breakdown Data by Application
  • 10.3 Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Breakdown Data by Countries
    • 10.3.1 Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales by Countries
    • 10.3.2 Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue by Countries
    • 10.3.3 Turkey
    • 10.3.4 GCC Countries
    • 10.3.5 Egypt
    • 10.3.6 South Africa

11 Company Profiles

  • 11.1 Eli Lilly
    • 11.1.1 Eli Lilly Company Details
    • 11.1.2 Company Description and Business Overview
    • 11.1.3 Sales, Revenue and Market Share of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
    • 11.1.4 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction
    • 11.1.5 Eli Lilly Recent Development
  • 11.2 Janssen Pharmaceuticals
    • 11.2.1 Janssen Pharmaceuticals Company Details
    • 11.2.2 Company Description and Business Overview
    • 11.2.3 Sales, Revenue and Market Share of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
    • 11.2.4 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction
    • 11.2.5 Janssen Pharmaceuticals Recent Development
  • 11.3 Astellas
    • 11.3.1 Astellas Company Details
    • 11.3.2 Company Description and Business Overview
    • 11.3.3 Sales, Revenue and Market Share of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
    • 11.3.4 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction
    • 11.3.5 Astellas Recent Development
  • 11.4 Boehringer Ingelheim
    • 11.4.1 Boehringer Ingelheim Company Details
    • 11.4.2 Company Description and Business Overview
    • 11.4.3 Sales, Revenue and Market Share of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
    • 11.4.4 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction
    • 11.4.5 Boehringer Ingelheim Recent Development
  • 11.5 AstraZeneca
    • 11.5.1 AstraZeneca Company Details
    • 11.5.2 Company Description and Business Overview
    • 11.5.3 Sales, Revenue and Market Share of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
    • 11.5.4 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction
    • 11.5.5 AstraZeneca Recent Development
  • 11.6 Bristol Myers Squibb
    • 11.6.1 Bristol Myers Squibb Company Details
    • 11.6.2 Company Description and Business Overview
    • 11.6.3 Sales, Revenue and Market Share of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
    • 11.6.4 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction
    • 11.6.5 Bristol Myers Squibb Recent Development
  • 11.7 Kotobuki Pharmaceutical
    • 11.7.1 Kotobuki Pharmaceutical Company Details
    • 11.7.2 Company Description and Business Overview
    • 11.7.3 Sales, Revenue and Market Share of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors
    • 11.7.4 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Product Introduction
    • 11.7.5 Kotobuki Pharmaceutical Recent Development

12 Value Chain and Sales Channels Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Sales Channels Analysis
    • 12.2.1 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Channels
    • 12.2.2 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Distributors
  • 12.3 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Customers

13 Market Forecast

  • 13.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales and Revenue Forecast 2019-2025
  • 13.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Type
  • 13.3 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Application
  • 13.4 Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Forecast by Regions
    • 13.4.1 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Regions 2019-2025
    • 13.4.2 Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Revenue Forecast by Regions 2019-2025
  • 13.5 North America Market Forecast
    • 13.5.1 North America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Forecast by Countries 2019-2025
    • 13.5.2 United States
    • 13.5.3 Canada
    • 13.5.4 Mexico
  • 13.6 Europe Market Forecast
    • 13.6.1 Europe Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Forecast by Countries 2019-2025
    • 13.6.2 Germany
    • 13.6.3 France
    • 13.6.4 UK
    • 13.6.5 Italy
    • 13.6.6 Russia
  • 13.7 Asia Pacific Market Forecast
    • 13.7.1 Asia Pacific Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Regions 2019-2025
    • 13.7.2 China
    • 13.7.3 Japan
    • 13.7.4 South Korea
    • 13.7.5 India
    • 13.7.6 Australia
    • 13.7.7 Indonesia
    • 13.7.8 Thailand
    • 13.7.9 Malaysia
    • 13.7.10 Philippines
    • 13.7.11 Vietnam
  • 13.8 Central & South America Market Forecast
    • 13.8.1 Central & South America Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Countries 2019-2025
    • 13.8.2 Brazil
  • 13.9 Middle East and Africa Market Forecast
    • 13.9.1 Middle East and Africa Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Sales Forecast by Countries 2019-2025
    • 13.9.2 Turkey
    • 13.9.3 GCC Countries
    • 13.9.4 Egypt
    • 13.9.5 South Africa

14 Research Findings and Conclusion

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
      • 15.1.1.1 Research Programs/Design
      • 15.1.1.2 Market Size Estimation
      • 15.1.1.3 Market Breakdown and Data Triangulation
    • 15.1.2 Data Source
      • 15.1.2.1 Secondary Sources
      • 15.1.2.2 Primary Sources
  • 15.2 Author Details
  • 15.3 Disclaimer
Back to Top